Jefferies bullish on Disc Medicine, calls bitopertin a blockbuster in the making
On Wednesday, Disc Medicine (NASDAQ:IRON) stock received a Buy rating from a Jefferies analyst, with a price target set at ...
On Wednesday, Disc Medicine (NASDAQ:IRON) stock received a Buy rating from a Jefferies analyst, with a price target set at ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.